Prof Robert McFarland

Clinical Senior Lecturer & Consultant Paediatric Neurologist, Wellcome Centre for Mitochondrial Research

Prof Robert McFarland (MA MBBS PhD MRCP MRCPCH) leads the Newcastle Paediatric Mitochondrial Disease Service, and together with Dr Jane Stewart and Prof Rob Taylor runs the Pre-implantation Genetic Diagnosis Service for Mitochondrial DNA Disease. His work focuses on understanding the causes of mitochondrial disease in children, and exploring the factors that influence disease expression. Prof McFarland is the national lead on the MRC Mitochondrial Disease Patient Cohort Study (UK). In 2006 he was appointed Honorary Consultant Paediatric Neurologist to the Newcastle-upon-Tyne NHS Hospitals Foundation Trust, and in 2008 was awarded a HEFCE/DoH Clinical Senior Lectureship in Paediatric Neurology.

Prof Douglas Turnbull

Director, Wellcome Centre for Mitochondrial Research

Prof Turnbull is the National lead of the National Highly Specialised Services for Rare Mitochondrial Diseases of Children and Adults. This involves three centres (Newcastle, London and Oxford) and provides diagnostic and specialist clinical services for patients with mitochondrial diseases. He is Professor of Neurology, University of Newcastle upon Tyne (1990-present), and an Honorary Consultant Neurologist at Newcastle-upon-Tyne Hospitals NHS Foundation Trust, and Director of Newcastle University Centre for Brain Ageing and Vitality. 

Dr Robert Pitceathly

Senior Research Associate, MRC Centre for Neuromuscular Diseases

Dr Robert Pitceathly completed his preclinical and clinical medical degree at St Andrews’ and Manchester Universities before commencing post-graduate neurology training in Manchester. He subsequently undertook a PhD in Mitochondrial Diseases at the UCL Institute of Neurology before obtaining an NIHR academic clinical lecturer post in London. His research combines clinical observations with laboratory approaches to develop understanding of the molecular basis underpinning Mitochondrial Disorders and reveal fundamental insights into disease mechanisms, with the ultimate aim of developing treatments for patients with Mitochondrial Disease. From March 2017 Dr Pitceathly will take on the role of Senior Research Associate at the MRC Centre for Neuromuscular Diseases, and will be actively involved in the weekly NHS England nationally commissioned mitochondrial clinic in addition to research studies in Mitochondrial Diseases.

Dr Victoria Nesbitt

Victoria is Clinical Lead for the Mitochondrial Disorders Service in Oxford, Consultant Paediatrician in Mitochondrial Diseases & Honorary Senior Clinical Lecturer in Paediatrics. Victoria strives to increase awareness of mitochondrial disease amongst clinicians in order to identify and diagnose children earlier allowing specialist management and genetic counselling to be instituted appropriately.

Prof Joanna Poulton

Professor and Honorary Consultant in Mitochondrial Genetics, Nuffield Department of Obstetrics & Gynaecology

Prof Jo Poulton is Professor and Honorary Consultant in Mitochondrial Genetics, Nuffield Department of Obstetrics and Gynaecology at the John Radcliffe Hospital, Oxford. Her main research interests are in the transmission of mutant mitochondrial DNA (mtDNA), and developing novel approaches to genetic counselling. 

Dr Mike Champion

Consultant in paediatric inherited metabolic diseases and clinical lead, Evelina Children's Hospital

Dr Champion studied medicine at King’s College London and then trained in children's medicine (paediatrics) before specialising in inherited metabolic diseases (IMD). He has been a consultant in metabolic medicine since 1998, and is the clinical lead for the IMD service at Evelina London Children's Hospital. He serves on the National Commissioning IMD Clinical Reference Group and the Rare Disorders Advisory Group, and is a Trustee of Evelina Children’s Fund. 

Prof Shamima Rahman

Shamima Rahman is Professor of Paediatric Metabolic Medicine at the UCL Institute of Child Health (ICH), and a consultant at Great Ormond Street Hospital for Children, London, where she sees children affected by mitochondrial diseases. Prof Rahman established the Mitochondrial Research Group at ICH in 2000. The aims of the ICH Mitochondrial Research Group are to find the causes of mitochondrial disease and to develop novel therapies for these currently incurable disorders. Prof Rahman is an Editor of the Journal of Inherited Metabolic Disease, and a member of the Education and Training Advisory Committee of the Society for the Study of Inborn Errors of Metabolism.

Dr Andrew Schaefer

Consultant Neurologist, Wellcome Centre for Mitochondrial Research

Dr Andrew Shaefer is a consultant neurologist specialising in neurogenetics, and has been associated with The Newcastle Mitochondrial Centre since 2001. Together with three consultant colleagues and support from our multidisciplinary team he helps run the Newcastle Mitochondrial Clinic and the clinical service for patients. Research interests include the natural history of the mitochondrial disorders, phenotype-genotype correlations and determining best clinical practice. Dr Schaefer has published on the prevalence of the mitochondrial disorders, and is the clinical lead on the development of best practice guidelines in mitochondrial disease.

Prof Robert Taylor

Professor of Mitochondrial Pathology, Wellcome Centre for Mitochondrial Research

R W Taylor PhD, DSc, FRCPath. Professor of Mitochondrial Pathology, Head of Laboratory, Newcastle Mitochondrial Diagnostic Service and Professor of Mitochondrial Pathology, Wellcome Centre for Mitochondrial Research, Newcastle University. Co-ordinating Consultant Clinical Scientist, UK NHS Highly Specialised Rare Mitochondrial Disease Service of Adults and Children.

Prof Mike Hanna

Professor Michael Hanna is a Professor in Clinical Neurology & Director of the UCL Institute of Neurology, overseeing an annual budget of £60m and a research staff of over 600. He is Director of the MRC Centre for Translational Research in Neuromuscular Disease, leads an active research programme and has published 200+ peer reviewed original research papers including New England Journal of Medicine and Lancet. Professor Hanna is committed to developing better services for patients, and runs two nationally commissioned services for mitochondrial disease and for neurological channelopathies.